Continuous treatment of non-sterile hospital wastewater by Trametes versicolor: How to increase fungal viability by means of operational strategies and pretreatments
Introduction
There is a growing concern among regulatory agencies and in the scientific community about pharmaceutical active compounds (PhACs) occurring in environmental water bodies. Although healthcare waste management is imperative, hospital wastewater (HWW), with similar pollutant load as urban wastewater but much higher concentrations of PhACs, is still commonly discharged into public sewage systems [1]. HWW constitutes the main source of PhACs in the influent of wastewater treatment plants (WWTP), which are not designed to remove these pollutants [2], [3]. Consequently, these effluents could be a vector to introduce PhACs in the environment through wastewater reuse purposes such as irrigation, landscape and surface or groundwater replenishment [4]. Therefore, a specific HWW treatment step before the HWW is mixed with urban wastewater would prevent PhAC contamination of the WWTP influent. Among the potential technologies for removing recalcitrant organic pollutants in wastewater, fungal treatment is a particularly promising strategy to biodegrade those pollutants due to their unspecific enzymatic systems. Several studies have reported the capacity of white rot fungi (and particularly Trametes versicolor) in degrading a wide range of emerging pollutants including PhACs [5], [6]. These studies have been carried out at different scales, from within Erlenmeyer flasks to bench bioreactors, and they have been conducted mainly in sterile conditions to best monitor the fungal degradation during the batch process. The studied pollutant concentrations are on the order of a few mg L−1, but the typical concentrations in wastewater are on the order of 1 ng L−1 [7], [8].
Moreover, the long-term operation of fungal biodegradation processes during a continuous fungal treatment of a synthetic textile wastewater, in sterile conditions, was demonstrated with a cellular retention time (CRT) of 21 days [9]. The biomass was retained in the reactor but periodic partial biomass removals were performed to limit the aging of the biomass and consequently to guarantee that metabolic activity occurred under growth-limiting conditions. However, the partial biomass renovation strategy was not enough to maintain fungus viability during the treatment of HWW under non-sterile conditions [8]. Few other references can be found that investigate the treatment of non-sterile wastewater by fungi in a continuous mode. The non-favorable competition between the inoculated fungus and the microorganisms in the real wastewater demonstrated the difficulty of developing an efficient treatment on an industrial scale due to the relatively short fungal viability time [10], [11], [12], [13].
A novel strategy to extend the fungal viability period has not yet been established and is essential to guarantee the long-term operation for the continuous treatment of HWW, which may be achieved through a continuous pumping of the influent or by sequential batch reactor (SBR) operation. In both strategies the biomass is retained in the bioreactor. In addition, a pretreatment for the HWW may reduce the bacteria level in the influent of the fungal bioreactor and consequently extend its viability. These processes include coagulation-flocculation and UV radiation, both methods widely used in WWTP [14], [15]. Their technology can be readily applied, but none of the methods have been used as pretreatments before.
Therefore, the main objective of this study is to increase the T. versicolor viability inside the reactor during a continuous treatment of non-sterile HWW. To achieve this, the following two approaches have been examined: first, the addition of two pretreatments, a coagulation-flocculation step and a UV irradiation step, and second, the continuous operation of the reactor and a SBR. The influence of both strategies on the viability period has been studied. The HWW was spiked with ibuprofen (IBU) and ketoprofen (KETO) for analytical purposes.
Section snippets
Reagents, fungus and hospital wastewater
Ketoprofen and ibuprofen were purchased from Sigma-Aldrich (Barcelona, Spain). Thiamine hydrochloride was acquired from Merck (Barcelona, Spain), peptone and yeast extract from Scharlau (Barcelona, Spain) and glucose, ammonium chloride and other chemicals were purchased from Sigma-Aldrich (Barcelona, Spain). PhACs were of HPLC purity grade (>99%) and all other chemicals used were of analytical grade.
T. versicolor (ATCC#42530) was maintained on 2% malt agar slants at 25 °C until use. Subcultures
Results and discussion
Three hospital wastewaters, HWW1 through HWW3, were characterized physically, chemically and biologically (Table 1). Most of the parameters are in the same range as other hospital effluents with the exception of conductivity and chloride concentration, which were higher than those reported [3], [7]. Although their concentrations were not uncommonly high, the COD and TSS concentrations in HWW3 were twice that in HWW1 and HWW2, while the ammonia concentration was very low. HWW3 also had the
Conclusions
Pretreating HWW with a coagulation-flocculation process can reduce the initial HPC level up to 104 cfu mL−1, which extended the fungal viability during the continuous treatment of a non-sterile real effluent. The addition of a UV pretreatment did not lead to better performance of the fungal bioreactor in terms of higher PhAC reductions or longer operation time. Testing of the operation modes indicated that continuous operation is preferred over SBR because the reduction capacity of T. versicolor
Acknowledgements
This work has been funded by the Spanish Ministry of Economy and Competitiveness (project CTM 2013-48545-C2-1-R) and partly supported by the Generalitat de Catalunya (Consolidated Research Group 2014-SGR-0476). The Department of Chemical Engineering of UAB is member of the Xarxa de Referència en Biotecnologia de la Generalitat de Catalunya. J.A. Mir-Tutusaus acknowledges the predoctoral grant from UAB.
References (37)
- et al.
Pharmaceuticals in hospital wastewater: their ecotoxicity and contribution to the environmental hazard of the effluent
Chemosphere
(2014) - et al.
What have we learned from worldwide experiences on the management and treatment of hospital effluent? An overview and a discussion on perspectives
Sci. Total Environ.
(2015) - et al.
The risks associated with wastewater reuse and xenobiotics in the agroecological environment
Sci. Total Environ.
(2011) - et al.
Removal of pharmaceuticals, steroid hormones, phytoestrogens, UV-filters, industrial chemicals and pesticides by Trametes versicolor: role of biosorption and biodegradation
Int. Biodeterior. Biodegrad.
(2014) - et al.
Ability of white-rot fungi to remove selected pharmaceuticals and identification of degradation products of ibuprofen by Trametes versicolor
Chemosphere
(2009) - et al.
Hospital wastewater treatment by fungal bioreactor: removal efficiency for pharmaceuticals and endocrine disruptor compounds
Sci. Total Environ.
(2014) - et al.
Identification of some factors affecting pharmaceutical active compounds (PhACs) removal in real wastewater. Case study of fungal treatment of reverse osmosis concentrate
J. Hazard. Mater.
(2015) - et al.
Study of the cellular retention time and the partial biomass renovation in a fungal decolourisation continuous process
Water Res.
(2006) - et al.
Degradation of pharmaceuticals in non-sterile urban wastewater by Trametes versicolor in a fluidized bed bioreactor
Water Res.
(2013) - et al.
Removal of bisphenol A and diclofenac by a novel fungal membrane bioreactor operated under non-sterile conditions
Int. Biodeterior. Biodegrad.
(2013)